Beaton Management Co. Inc. Bristol Myers Squibb CO Transaction History

Beaton Management Co. Inc.

$186 Million
Q2 2024

A detailed history of Beaton Management Co. Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beaton Management Co. Inc. holds 20,424 shares of BMY stock, worth $1.02 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

20,424

Previous 20,424 -0.0%

Holding current value

$1.02 Million

Previous $1.11 Million 23.47%

% of portfolio

0.46%

Previous 0.6%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $23,990 - $27,200	500 Added 2.51%	20,424 $1.11 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $6,496 - $7,751	-134 Reduced 0.67%	19,924 $1.02 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $5,789 - $6,473	-100 Reduced 0.5%	20,058 $1.16 Million
Q2 2023 Jul 21, 2023	BUY	$63.71 - $70.74 $31,855 - $35,370	500 Added 2.54%	20,158 $1.29 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $3,074 - $3,686	50 Added 0.25%	19,658 $1.44 Million
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $11,798 - $13,754	220 Added 1.13%	19,608 $1.22 Million
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $44,673 - $52,329	755 Added 4.05%	19,388 $1.15 Million
Q4 2020 Feb 17, 2021	SELL	$57.74 - $65.43 $11,548 - $13,086	-200 Reduced 1.06%	18,633 $1.16 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $16,080 - $17,819	-280 Reduced 1.46%	18,833 $1.14 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $34,800 - $50,572	750 Added 4.08%	19,113 $1.07 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $29,526 - $38,514	600 Added 3.38%	18,363 $1.18 Million
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $37,637 - $44,624	-880 Reduced 4.72%	17,763 $901,000
Q2 2019 Aug 15, 2019	SELL	$44.62 - $49.34 $35,071 - $38,781	-786 Reduced 4.05%	18,643 $845,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $58,204 - $69,402	-1,290 Reduced 6.23%	19,429 $927,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $73,140 - $94,845	-1,500 Reduced 6.75%	20,719 $1.08 Million
Q3 2018 Nov 16, 2018	SELL	$55.19 - $62.25 $22,627 - $25,522	-410 Reduced 1.81%	22,219 $1.38 Million
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $32,844 - $40,937	-650 Reduced 2.79%	22,629 $1.25 Million
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $17,982 - $19,605	300 Added 1.31%	23,279 $1.43 Million
Q2 2017 Aug 17, 2017	BUY	N/A	22,979	22,979 $1.28 Million

Others Institutions Holding BMY

# of Institutions

2,399

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $106B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beaton Management Co. Inc. with notifications on news.

Account

Beaton Management Co. Inc. Bristol Myers Squibb CO Transaction History